Exome sequencing greatly expedites the progressive research of Mendelian diseases
Author:
- 3 January 2014
- journal article
- review article
- Published by Springer Nature in Frontiers of Medicine
- Vol. 8 (1) , 42-57
Abstract
The advent of whole-exome sequencing (WES) has facilitated the discovery of rare structure and functional genetic variants. Combining exome sequencing with linkage studies is one of the most efficient strategies in searching disease genes for Mendelian diseases. WES has achieved great success in the past three years for Mendelian disease genetics and has identified over 150 new Mendelian disease genes. We illustrate the workflow of exome capture and sequencing to highlight the advantages of WES. We also indicate the progress and limitations of WES that can potentially result in failure to identify disease-causing mutations in part of patients. With an affordable cost, WES is expected to become the most commonly used tool for Mendelian disease gene identification. The variants detected cumulatively from previous WES studies will be widely used in future clinical services.Keywords
This publication has 174 references indexed in Scilit:
- Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with theAPOEp.Leu167del MutationHuman Mutation, 2012
- Exome sequencing reveals DNAJB6 mutations in dominantly‐inherited myopathyAnnals of Neurology, 2011
- Whole-Exome-Sequencing-Based Discovery of Human FADD DeficiencyThe American Journal of Human Genetics, 2010
- MASP1 Mutations in Patients with Facial, Umbilical, Coccygeal, and Auditory Findings of Carnevale, Malpuech, OSA, and Michels SyndromesThe American Journal of Human Genetics, 2010
- Mutations in SCARF2 Are Responsible for Van Den Ende-Gupta SyndromeThe American Journal of Human Genetics, 2010
- Exome Sequencing in Brown-Vialetto-Van Laere SyndromeThe American Journal of Human Genetics, 2010
- Exome Sequencing Identifies WDR35 Variants Involved in Sensenbrenner SyndromeThe American Journal of Human Genetics, 2010
- Mutations in the DBP-Deficiency Protein HSD17B4 Cause Ovarian Dysgenesis, Hearing Loss, and Ataxia of Perrault SyndromeThe American Journal of Human Genetics, 2010
- Terminal Osseous Dysplasia Is Caused by a Single Recurrent Mutation in the FLNA GeneThe American Journal of Human Genetics, 2010
- Whole Exome Sequencing and Homozygosity Mapping Identify Mutation in the Cell Polarity Protein GPSM2 as the Cause of Nonsyndromic Hearing Loss DFNB82The American Journal of Human Genetics, 2010